A Long-term Follow-up Study in Participants Who Received CS-101

ConditionBeta-Thalassemia

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age3-17

SponsorChildren's Hospital of Fudan University

About this trial

This is a study to evaluate the long-term safety and efficacy of CS-101 in participants who received CS-101 in study CS -101-03 (NCT06065189)

Eligibility criteria

Qualifiers

Participants (or his or her legally appointed and authorized representative or guardian) must sign and date informed consent form (ICF) and, where applicable, an assent form

Participants must have received CS-101 infusion in last IIT study

Disqualifiers

There are no exclusion criteria

Trial design

Treatments tested in this trial

CS-101

Treatment groups

5 Participants

are divided into 1 treatment group

Sponsors and collaborators

Children's Hospital of Fudan University

Lead sponsor

Source ClinicalTrials.gov